Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 28;24(11):2030.
doi: 10.3390/molecules24112030.

Synthesis and Chemical Properties of 3-Phosphono-coumarins and 1,2-Benzoxaphosphorins as Precursors for Bioactive Compounds

Affiliations
Review

Synthesis and Chemical Properties of 3-Phosphono-coumarins and 1,2-Benzoxaphosphorins as Precursors for Bioactive Compounds

Ana I Koleva et al. Molecules. .

Abstract

Coumarins are an important class of natural heterocyclic compounds that have attracted considerable synthetic and pharmacological interest due to their various biological activities. This review emphasizes on the synthetic methods for the preparation of dialkyl 2-oxo-2H-1-benzo- pyran-3-phosphonates and alkyl 1,2-benzoxaphosphorin-3-carboxylates. Their chemical properties as acceptors in conjugate addition reactions, [2+2] and [3+2] cycloaddition reactions are discussed.

Keywords: 1,2-bezoxaphosphorines; 1,2-bezoxaphosphorines-3-phosphonic acid; 1,2-phosphorinines; 2-oxo-2H-1-benzopyrans; 2-oxo-2H-chromenes; [2+2] cycloaddition; [3+2] cycloaddition; conjugate addition; coumarins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Phosphorus-containing structures 1 and its phosphoroheterocyclic analogue 2.
Figure 2
Figure 2
Biologically active compounds and drugs.
Scheme 1
Scheme 1
Knoevenagel condensation reaction of salicylaldehyde (3a) with triethyl phosphono- acetate (4).
Scheme 2
Scheme 2
Different synthetic methods for the formation of 3-dialkylphosphonocoumarins 1.
Scheme 3
Scheme 3
Knoevenagel condensation reaction with piperidine as catalyst.
Scheme 4
Scheme 4
Knoevenagel condensation reaction with organic and inorganic catalysts.
Scheme 5
Scheme 5
Different reaction paths explaining the ratio of the products 1 and 2.
Figure 3
Figure 3
Titanium chelate-complex formation.
Scheme 6
Scheme 6
Reaction of 2′-bromoacetoxyphenones 8ae with trimethyl phosphite (9).
Scheme 7
Scheme 7
Reaction with compound 10.
Scheme 8
Scheme 8
Synthetic method uses vinylphosphonates and phenols.
Scheme 9
Scheme 9
Catalytic phosphorylation with Mn(OAc)3.
Scheme 10
Scheme 10
Catalytic phosphorylation with Pd-complexes.
Scheme 11
Scheme 11
Proposed mechanism for the synthesis of substituted dialkyl 2-oxo-2H-1-benzopyran-3-phosphonates.
Scheme 12
Scheme 12
Ag-catalyzed phosphorylation reaction.
Scheme 13
Scheme 13
The proposed radical mechanism of the Ag-catalyzed phosphorylation reaction.
Scheme 14
Scheme 14
Phosphorylation reactions by N-heterocyclic carbene palladium complexes.
Scheme 15
Scheme 15
Electrochemical phosphorylation of coumarins with diethyl H-phosphonate.
Scheme 16
Scheme 16
Electrochemical phosphorylation of coumarins with dialkyl H-phosphonate.
Scheme 17
Scheme 17
Synthesis of 3-diethylphosphonocoumarin under coupling reaction.
Scheme 18
Scheme 18
Possible mechanism of the reaction involving ortho-quinone methide.
Scheme 19
Scheme 19
Transition-metal-catalyzed cross-coupling synthetic protocol for the formation of phosphorus-containing coumarin systems.
Scheme 20
Scheme 20
The suggested mechanism of the observed cross-coupling transformation.
Scheme 21
Scheme 21
Cascade-radical approach for the formation of 3-functionalized coumarin.
Scheme 22
Scheme 22
Rearrangement reaction of intermediate A.
Figure 4
Figure 4
Nucleophilic addition reactions to 3-dialkylphosphonocoumarin.
Figure 5
Figure 5
Structures of phosphorus-containing coumarins that were object of theoretical investigations.
Scheme 23
Scheme 23
One-pot tandem hydrogenation/acylation reactions with 3-diethylphosphonocoumarin 1a.
Figure 6
Figure 6
Products isolated from acylation reaction.
Scheme 24
Scheme 24
Reaction of 3-diethylphosphonocoumarin 1a with Grignard reagent.
Scheme 25
Scheme 25
1,4-conjugate addition reactions with organometallic compounds.
Scheme 26
Scheme 26
Reactions with organozinc reagents.
Scheme 27
Scheme 27
Radical homodimerization mechanism.
Scheme 28
Scheme 28
1,4-conjugate addition reactions to 4-substituted 3-diethylphosphonocoumarins.
Scheme 29
Scheme 29
Reaction of 1a with cyclohexanone and N-methylglycine.
Scheme 30
Scheme 30
Proposed ylide structure 30 and subsequent interactions.
Scheme 31
Scheme 31
Domino reaction with azomethine ylides.
Scheme 32
Scheme 32
Synthesis of polycyclic δ-lactams.
Scheme 33
Scheme 33
Michael-type addition of nitromethane under different reaction conditions.
Scheme 34
Scheme 34
Proposed mechanism for the formation of 45 and 46.
Scheme 35
Scheme 35
Michael addition of enolizable ketones to 3-diethylphosphonocoumarin 1 using TBD and Cs2CO3.
Figure 7
Figure 7
Proposed synclinal transition state formation.
Scheme 36
Scheme 36
Michael addition of enolizable ketones to 3-phosphonocoumarin 1 using TBD.
Scheme 37
Scheme 37
Synthesis of dialkyl 1,2-benzoxaphosphorin-3-phosphonates 55 via Knoevenagel reaction.
Scheme 38
Scheme 38
Horner-Wadsworth-Emmons reaction catalyzed by DBU.
Figure 8
Figure 8
The structures of obtained 1,2-benzophosphorins of type 2.
Scheme 39
Scheme 39
Reactions involving oxaphospholes.
Scheme 40
Scheme 40
Multistep procedure for obtaining P-heterocyclic products.
Figure 9
Figure 9
Another example of compounds 61.
Scheme 41
Scheme 41
Condensation of a phosphorus-bearing component with substituted phenols.
Scheme 42
Scheme 42
Gold-catalyzed hydroarylation of aryl alkynylphosphonates.
Scheme 43
Scheme 43
Intramolecular Pd-catalyzed cyclization reaction.
Scheme 44
Scheme 44
Proposed mechanism of the intramolecular Pd-catalyzed cyclization reaction.
Scheme 45
Scheme 45
Formation of 1,2-benzoxaphosphorines 70.
Scheme 46
Scheme 46
Alkylation reaction to products 70 and 71.
Scheme 47
Scheme 47
Conditions and results for the coupling reactions.
Scheme 48
Scheme 48
Palladium-catalyzed Heck reaction.
Scheme 49
Scheme 49
Accomplishing a Diels-Alder reaction with compounds 76.
Figure 10
Figure 10
Cyclized stereoisomers.
Scheme 50
Scheme 50
[2+2] Cycloaddition products.
Scheme 51
Scheme 51
[3+2] Cycloaddition reaction of 3-diethylphosphonocoumarins 1a and 1c.
Scheme 52
Scheme 52
[3+2] Cycloaddition reaction of 1,2-benzoxaphosphorines 2d and 55a,b.

References

    1. Borges F., Roleira F., Milhazes N., Santana L., Uriarte E. Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Curr. Med. Chem. 2005;12:887–916. doi: 10.2174/0929867053507315. - DOI - PubMed
    1. Riveiro M.E., De Kimpe N., Moglioni A., Vázquez R., Monczor F., Shayo C., Davio C. Coumarins: Old compounds with novel promising therapeutic perspectives. Curr. Med. Chem. 2010;17:1325–1338. doi: 10.2174/092986710790936284. - DOI - PubMed
    1. Chen S., Cho M., Karlsberg K., Zhou D., Yuan Y.-C. Biochemical and Biological Characterization of a Novel Anti-aromatase Coumarin Derivative. J. Biol. Chem. 2004;279:48071–48078. doi: 10.1074/jbc.M406847200. - DOI - PubMed
    1. Kulkarni M.V., Kulkarni G.M., Lin C.-H., Sun C.-M. Recent Advances in Coumarins and 1-Azacoumarins as Versatile Biodynamic Agents. Curr. Med. Chem. 2006;13:2795–2818. doi: 10.2174/092986706778521968. - DOI - PubMed
    1. Al-Majedy Y., Kadhum A.A., Ibraheem H., Al-Amiery A., Moneim A.A., Mohamad A.B. A Systematic Review on Pharmacological Activities of 4-Methylumbelliferon. Sys. Rev. Pharm. 2018;9:49–54. doi: 10.5530/srp.2018.1.10. - DOI

MeSH terms

LinkOut - more resources